Stroke prevention in atrial fibrillation: Closing the gap

Am Heart J. 2019 Apr:210:29-38. doi: 10.1016/j.ahj.2018.10.004. Epub 2018 Oct 25.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Aspirin / administration & dosage
  • Atrial Fibrillation / complications*
  • Atrial Fibrillation / diagnosis
  • Dabigatran / administration & dosage
  • Health Services Misuse / statistics & numerical data
  • Hemorrhage / chemically induced
  • Humans
  • International Normalized Ratio / statistics & numerical data
  • Pyrazoles / administration & dosage
  • Pyridines / administration & dosage
  • Pyridones / administration & dosage
  • Rivaroxaban / administration & dosage
  • Septal Occluder Device
  • Stroke / etiology
  • Stroke / prevention & control*
  • Thiazoles / administration & dosage
  • Warfarin / administration & dosage
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • apixaban
  • Warfarin
  • Rivaroxaban
  • Dabigatran
  • edoxaban
  • Aspirin